
|Articles|November 1, 2007
B&L merger approved
Bausch & Lomb's shareholders have voted to approve a merger with Warburg Pincus.
Advertisement
Bausch & Lomb's shareholders have voted to approve a merger with Warburg Pincus.
In accordance with the terms of the merger, each outstanding share of common and Class B stock will be cancelled and converted into the right to receive $65 in cash, without interest, less any applicable withholding taxes.
The merger is expected to close early in the fourth quarter of this year.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
4
Real-world VOYAGER data on faricimab in nAMD, DME, RVO at EURETINA 2026
5



















